Piperazine → 11-(Piperazin-1-yl)dibenzo(b,f)(1,4)oxazepine
反応式
[CH:1]1[C:6]2[C:7](=O)[NH:8][C:9]3[CH:15]=[CH:14][CH:13]=[CH:12][C:10]=3[O:11][C:5]=2[CH:4]=[CH:3][CH:2]=1.[NH:17]1[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]1.[OH-].[NH4+]>C1(C)C=CC=CC=1.Cl[Ti](Cl)(Cl)Cl>[N:17]1([C:7]2[C:6]3[CH:1]=[CH:2][CH:3]=[CH:4][C:5]=3[O:11][C:10]3[CH:12]=[CH:13][CH:14]=[CH:15][C:9]=3[N:8]=2)[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]1参加物
6
実験手順
To a stirred solution of 10, 11-dihydro-dibenz[b,f][1,4]oxazepin-11-one in dry toluene at room temperature was added piperazine (Aldrich) followed by the dropwise addition of TiCl4. The reaction mixture was refluxed for 2 hours, cooled to room temperature and then poured into an ammonium hydroxide solution. The resulting mixture was extracted with dichloromethane, and the combined organic phases were then dried (K2CO3) and concentrated. Purification of the product was conducted on silica gel using ethyl acetate:hexane (5:1→4:1) as the eluant to give the title compound.
後処理
- temperatureThe reaction mixture was refluxed for 2 hours
- extractionThe resulting mixture was extracted with dichloromethane
- dry with materialthe combined organic phases were then dried (K2CO3)
- concentrationconcentrated
- customPurification of the product
出典と根拠
- ORDレコード
- ord-e2c16a857f2e4b02a37fd904c63a0bdd
- 出典データセット
- uspto-grants-1997_02
- 特許番号
- US05602121
反応ノート
読み込み中…